Propanc Biopharma, Inc. (PPCB)
OTCMKTS · Delayed Price · Currency is USD
5.25
-0.25 (-4.55%)
Apr 4, 2025, 2:39 PM EST

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
0010--
Upgrade
Market Cap Growth
-50.41%-25.62%26.73%---
Upgrade
Enterprise Value
1111--
Upgrade
Last Close Price
5.2574.858083.83220059.883095808.383900.00
Upgrade
PB Ratio
-0.04-0.11-0.18-0.15--
Upgrade
Debt / Equity Ratio
-0.29-0.25-0.17-0.34-0.22-0.45
Upgrade
Quick Ratio
0.000.010.000.000.000.02
Upgrade
Current Ratio
0.000.010.010.010.000.02
Upgrade
Return on Assets (ROA)
-462.23%-1447.01%-1564.19%-2626.42%-2029.40%-2182.06%
Upgrade
Earnings Yield
-2308.13%-438.79%-476.99%-603.95%--
Upgrade
FCF Yield
-364.59%-225.39%-198.15%-326.34%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.